Transcriptome data of multiple sclerosis patients receiving fingolimod therapy

This SuperSeries is composed of the SubSeries listed below. Using 150 Affymetrix HTA 2.0 microarrays, we profiled the gene expression of 5 cell populations of the peripheral blood from patients with multiple sclerosis in the course of fingolimod treatment. Refer to individual Series Please note that HTA 2.0 data can be processed according to two different workflows: exon level (GEO platform GPL17585) and gene level (GEO platform GPL17586). This SuperSeries contains each of the 150 CEL files twice, because they had to be submitted for both, the exon level records and the gene level records.

本超级数据集（SuperSeries）由下述子数据集（SubSeries）构成。本研究采用150套Affymetrix HTA 2.0基因芯片，对多发性硬化（multiple sclerosis）患者接受芬戈莫德（fingolimod）治疗期间的外周血5种细胞群体开展了基因表达谱分析。请参阅各子数据集以获取详细信息。请注意，HTA 2.0数据可通过两种不同的分析流程进行处理：外显子水平（GEO平台GPL17585）与基因水平（GEO平台GPL17586）。由于需分别提交外显子水平与基因水平的相关记录，本超级数据集将150份CEL文件各留存两份。